This report identifies key demand-side trends in the clinical data management business process transformation services space to help enterprises fine-tune their operations. It provides an overview of key observations and business challenges that Avasant considers important to highlight in the clinical data management and clinical trials outsourcing space.

Why read this Market Insights?

The clinical data management and clinical trials services market is undergoing a transformation driven by global economic uncertainties, rising drug development costs, and a focus on patient-centric engagement. Life sciences organizations are partnering with CROs, KPOs, and BPOs to access specialized expertise, expedite time to market, and enhance data management capabilities. There is a growing trend toward decentralized clinical trial and hybrid clinical trial models to improve patient recruitment and retention, while also expanding clinical trials globally for inclusivity.

The Clinical Data Management Business Process Transformation 2024–2025 Market Insights™ aids organizations in identifying important market trends and expectations for any clinical data management services projects they engage in.

Methodology

The industry insights presented in this report are based on the following: our ongoing interactions with enterprise CXOs and other key executives; targeted discussions with service providers, subject matter experts, and Avasant Fellows; analyst insights from primary and secondary research; and lessons learned from consulting engagements.

Table of contents

About the report (Page 3)

Executive summary (Pages 4–7)

• • Definition and scope of clinical data management business process transformation services
  • Clinical data management business process transformation trends
  • Avasant recognizes 19 top-tier providers offering clinical data management business process transformation services

Demand-side trends (Pages 8–13)

• • Advanced technologies and a patient-centric focus are driving the growth of decentralized and hybrid trials.
  • Sponsors are increasingly outsourcing clinical trial research activities to reduce expenditure.
  • Automation, AI, and ML are helping sponsors in reducing expenditures on clinical trials and data management.
  • Clinical trial sponsors are seeking global trials to access real-world data, increase patient diversity, and comply with regulatory standards.
  • Sponsors are leveraging adaptive trial designs for emerging therapy trials to expedite time to market.

Key contacts (Page 14)

Read the Research Byte based on this report. Please refer to Avasant’s Clinical Data Management Business Process Transformation 2024–2025 RadarView™ for detailed insights on the service providers and supply-side trends.